HOLD

• Current close at $607.17 is $11.17 above the 10-day EMA at $596, indicating extended entry point after 19.3% one-month rally
• RSI at 63.69 approaching but not yet at 70 overbought threshold
• Conservative stop reference at $584 represents approximately 3.7% downside from current levels
• Aggressive target of $660-$690 represents 8-15% upside but requires Q3 earnings confirmation, multiple expansion, and geopolitical stability to materialize
• Q2 2026 quarterly op margin sequence: 4.1, 12.3, 11.5, 11.4, 12.4 — Q2 sits at high end of tight normalization band
• Buybacks cut from $7.9 billion in 2022 to $3 billion in 2025, now zero in first half 2026, removing EPS tailwind from shrinking share count
• Forward consensus EPS of $32.72 already priced by market, limiting post-Q3 upside if it merely meets expectations
• Polymarket contract on formal U.S. war declaration sits at just 3%, constraining geopolitical escalation premium
• Aggressive first tranche sizing as 'meaningful overweight to benchmark' creates meaningful drawdown risk if Q3 disappoints
• Sector peer set down 17% on average — LMT's relative outperformance may indicate further catch-down rather than decoupling

→ vs aggressive: Forward EPS thesis at $32.72 with 21x multiple requires all three legs (EPS delivery, multiple hold, macro support) to hold simultaneously; only one needs to break for the entry to be a mistake

→ vs aggressive: Q2 2026 revenue up 10.5% and EPS of $7.94 versus $1.46 comparison represents margin normalization to 12.4%, not expansion — the information is already in the price

→ vs aggressive: Sector rotation/LMT decoupling thesis is unproven; single-stock outperformance during sector drawdown historically becomes catch-down when mean reversion occurs

→ vs aggressive: Buyback pause reframed as balance sheet strength is more accurately a withdrawal; management reducing capital return implies funding need or flexibility preservation

→ vs aggressive: Pre-earnings accumulation window works until it doesn't — any Q3 miss would cause gap below $596 where technical framework stops working

→ vs aggressive: Geopolitical tension framed as structural has a 3% formal war declaration probability on Polymarket; de-escalation signals could compress the conflict premium even if demand thesis holds

→ vs aggressive: No-aggressive-entry-above-$607 rule defends entry quality; buying strength after 19.3% monthly move is buying momentum that fails in choppy tape

HOLD

• Structural bull case intact: largest defense prime, accelerating revenue, $12.15B deferred revenue, 13-year dividend growth streak, Q2 margin recovery confirmed at 12.4%
• Current valuation at 18.5x forward P/E ($607 price / $32.72 EPS) requires ~2.5 turn multiple expansion to reach $660-$690 target, viewed as low-probability
• LMT's 19.3% monthly rally vs sector's 17% decline is likely a relief bid from July lows rather than confirmed decoupling, creating uncertainty for next 4-6 weeks
• Q2 operating margin of 12.4% represents recovery trajectory (12.3, 11.5, 11.4, 12.4) rather than a ceiling or floor
• Buyback pause ($7.9B to zero) accompanied by net debt reduction ($17.58B to $16.75B) and cash rebuild ($1.29B to $3.79B), viewed as balance sheet repair flexibility
• Proposed small starter position at current levels ($607) represents 25-33% of intended first tranche, with bulk staged at $596 and $584
• Stop framework distinguishes $584 as tactical reduction trigger (cut 50% on close below with MACD/signal crossover and RSI breaking 50) vs structural exit at $545 (50-day SMA), which is more sophisticated than conservative's hard stop or aggressive's advisory approach
• Defensive: $584 stop is only 3.7% below $607, equal to ~1.4 standard deviations given $15.51 ATR (2.6% daily volatility), making it tight but meaningful
• Pre-Q3 earnings binary catalyst argues against overweight; defense-sector benchmark weight is appropriate anchor
• Reassess into Q3 earnings and FY27 budget markup cycle; geopolitical tailwinds from Hormuz and NATO burden-sharing are real but being questioned by the tape

→ vs aggressive: Decoupling argument is premature after 30 days; LMT's rally was likely a relief bid, not structural leadership - market hasn't confirmed which interpretation is correct

→ vs aggressive: $660-$690 target requires 14% multiple expansion on top of consensus earnings - aggressive multiple expansion leg is low-probability in a name where growth is normalizing, not accelerating

→ vs aggressive: First tranche should not be a meaningful overweight as advocated; technical setup doesn't justify conviction overweight ahead of Q3 binary catalyst

→ vs conservative: ATR-based risk/reward treating LMT like a momentum chart ignores $12.15B deferred revenue, 13-year dividend growth streak, and backlog - that's analytical mistake dressed in quantitative language

→ vs conservative: $584 hard stop is tighter than it appears given $15.51 ATR (2.6% daily volatility); 3.7% buffer is ~1.4 standard deviations that will be tested on ordinary trading days

→ vs conservative: Q2 margin of 12.4% should be framed as recovery confirmation (four-quarter trajectory of 12.3, 11.5, 11.4, 12.4) rather than high-end normalization - both analyst framings are incomplete

→ vs conservative: Buyback pause framing as 'absence' is wrong; it's management optionality to resume at higher prices if Q3 prints well